Delivery Order SPE2DB20D1004-SPE2DB24FG5B0

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,194.07 firm fixed-price delivery order is for the supply of 4,559,929,808 units of Ondansetron HCL 8 mg tablets, with a completion date of February 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,489.63 firm-fixed-price delivery order is for 4,567,052,683 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,248.23, is a firm fixed-price delivery order for 4,563,202,968 units of the medication Ondansetron HCL 8 mg Tablet 30s. The contract has an ultimate completion date of January 2, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,653.78 Firm Fixed Price delivery order is for the supply of 4,565,550,885 units of the drug Ondansetron HCL 8 MG Tablet, with a completion date of August 23, 2024. This award is a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,369.34 firm fixed-price delivery order is for 4,562,925,729 units of 4 mg Ondansetron HCL tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides $10,009.92 in firm fixed-price funding for the delivery of 4,567,461,841 units of the generic medication Ondansetron HCL 8 mg tablets. The contract, which has a completion date of March 5, 2025, was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,729.60 firm fixed-price delivery order contract is for the supply of 4565863707 - Ondansetron HCL 8 mg Tablets in 30-count packages. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,863.89 firm fixed-price delivery order is for the supply of 4,564,603,718 units of Ondansetron ODT 4 mg tablets in 30-count packages. The contract has a completion date of May 15, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,330.41 firm fixed-price delivery order is for the supply of 4,566,471,926 units of Ondansetron HCL 8 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,573,144 units of Ondansetron HCL 4 mg tablets. The $4,383.54 firm fixed-price contract has an ultimate completion date of December 2, 2024. This award is a delivery order placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FG5B0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,377.65 firm-fixed-price delivery order is for the supply of 4,565,219,948 units of the medication Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's significant role as a critical vendor for the federal government's pharmaceutical and medical supply needs, particularly within the military and veterans' healthcare systems.

Generated 2/27/25, 11:53 AM